These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


327 related items for PubMed ID: 24421401

  • 21. Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates.
    Alper RH, Nelson DL.
    Eur J Pharmacol; 2000 Feb 25; 390(1-2):67-73. PubMed ID: 10708708
    [Abstract] [Full Text] [Related]

  • 22. Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability.
    Zazpe A, Artaiz I, Labeaga L, Lucero ML, Orjales A.
    Neuropharmacology; 2007 Mar 25; 52(3):975-84. PubMed ID: 17141811
    [Abstract] [Full Text] [Related]

  • 23. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM, Monge A, Del Río J, Lasheras B.
    Eur J Pharmacol; 2002 May 03; 442(1-2):63-71. PubMed ID: 12020683
    [Abstract] [Full Text] [Related]

  • 24. Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects.
    Bortolozzi A, Castañé A, Semakova J, Santana N, Alvarado G, Cortés R, Ferrés-Coy A, Fernández G, Carmona MC, Toth M, Perales JC, Montefeltro A, Artigas F.
    Mol Psychiatry; 2012 Jun 03; 17(6):612-23. PubMed ID: 21808255
    [Abstract] [Full Text] [Related]

  • 25. The G Protein-Coupled Serotonin 1A Receptor Augments Protein Kinase Cε-Mediated Neurogenesis in Neonatal Mouse Hippocampus-PKCε-Mediated Signaling in the Early Hippocampus.
    Samaddar S, Purkayastha S, Diallo S, Tantry SJ, Schroder R, Chanthrakumar P, Flory MJ, Banerjee P.
    Int J Mol Sci; 2022 Feb 10; 23(4):. PubMed ID: 35216076
    [Abstract] [Full Text] [Related]

  • 26. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
    Knobelman DA, Hen R, Blendy JA, Lucki I.
    J Pharmacol Exp Ther; 2001 Sep 10; 298(3):1092-100. PubMed ID: 11504806
    [Abstract] [Full Text] [Related]

  • 27. 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors.
    Eriksson TM, Holst S, Stan TL, Hager T, Sjögren B, Ogren SÖ, Svenningsson P, Stiedl O.
    Neuropharmacology; 2012 Nov 10; 63(6):1150-60. PubMed ID: 22801295
    [Abstract] [Full Text] [Related]

  • 28. Regulators of G-protein signaling 4: modulation of 5-HT1A-mediated neurotransmitter release in vivo.
    Beyer CE, Ghavami A, Lin Q, Sung A, Rhodes KJ, Dawson LA, Schechter LE, Young KH.
    Brain Res; 2004 Oct 01; 1022(1-2):214-20. PubMed ID: 15353231
    [Abstract] [Full Text] [Related]

  • 29. BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities.
    Quesseveur G, David DJ, Gaillard MC, Pla P, Wu MV, Nguyen HT, Nicolas V, Auregan G, David I, Dranovsky A, Hantraye P, Hen R, Gardier AM, Déglon N, Guiard BP.
    Transl Psychiatry; 2013 Apr 30; 3(4):e253. PubMed ID: 23632457
    [Abstract] [Full Text] [Related]

  • 30. Aging alters in a region-specific manner serotonin transporter sites and 5-HT(1A) receptor-G protein interactions in hamster brain.
    Duncan MJ, Hensler JG.
    Neuropharmacology; 2002 Jul 30; 43(1):36-44. PubMed ID: 12213257
    [Abstract] [Full Text] [Related]

  • 31. Cholesterol reduction attenuates 5-HT1A receptor-mediated signaling in human primary neuronal cultures.
    Sjögren B, Csöregh L, Svenningsson P.
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Oct 30; 378(4):441-6. PubMed ID: 18607571
    [Abstract] [Full Text] [Related]

  • 32. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
    Dekeyne A, Brocco M, Adhumeau A, Gobert A, Millan MJ.
    Psychopharmacology (Berl); 2000 Sep 30; 152(1):55-66. PubMed ID: 11041316
    [Abstract] [Full Text] [Related]

  • 33. Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment.
    Scorza MC, Lladó-Pelfort L, Oller S, Cortés R, Puigdemont D, Portella MJ, Pérez-Egea R, Alvarez E, Celada P, Pérez V, Artigas F.
    Br J Pharmacol; 2012 Nov 30; 167(5):1021-34. PubMed ID: 22050051
    [Abstract] [Full Text] [Related]

  • 34. Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in human neocortex slices: involvement of 5-HT(2C) and 5-HT(1A) receptors.
    Maura G, Marcoli M, Pepicelli O, Rosu C, Viola C, Raiteri M.
    Br J Pharmacol; 2000 Aug 30; 130(8):1853-8. PubMed ID: 10952674
    [Abstract] [Full Text] [Related]

  • 35. Roles of 5-HT(1A) receptors in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioral effects of 8-OH-DPAT and S 15535 in a modified Geller-Seifter conflict model.
    Cervo L, Mocaër E, Bertaglia A, Samanin R.
    Neuropharmacology; 2000 Apr 03; 39(6):1037-43. PubMed ID: 10727714
    [Abstract] [Full Text] [Related]

  • 36. Differential coupling of 5-HT1A receptors occupied by 5-HT or 8-OH-DPAT to adenylyl cyclase.
    Varrault A, Bockaert J.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct 03; 346(4):367-74. PubMed ID: 1436121
    [Abstract] [Full Text] [Related]

  • 37. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A, Sebben M, Bockaert J.
    Mol Pharmacol; 1988 Feb 03; 33(2):178-86. PubMed ID: 2828913
    [Abstract] [Full Text] [Related]

  • 38. Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function.
    Saunders C, Siuta M, Robertson SD, Davis AR, Sauer J, Matthies HJG, Gresch PJ, Airey D, Lindsley CW, Schetz JA, Niswender KD, Veenstra-Vanderweele JM, Galli A.
    Neurochem Int; 2014 Jul 03; 73():113-121. PubMed ID: 24090638
    [Abstract] [Full Text] [Related]

  • 39. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.
    Guilloux JP, David DJ, Guiard BP, Chenu F, Repérant C, Toth M, Bourin M, Gardier AM.
    Neuropsychopharmacology; 2006 Oct 03; 31(10):2162-72. PubMed ID: 16452992
    [Abstract] [Full Text] [Related]

  • 40. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
    Meller E, Li H, Carr KD, Hiller JM.
    J Pharmacol Exp Ther; 2000 Feb 03; 292(2):684-91. PubMed ID: 10640306
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.